.

BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Citi
Moodys
Boehringer Ingelheim
Argus Health
Medtronic
Dow
Federal Trade Commission
Cantor Fitzgerald
Cerilliant
Mallinckrodt

Generated: September 24, 2017

DrugPatentWatch Database Preview

Claims for Patent: ► Subscribe

« Back to Dashboard

Claims for Patent: ► Subscribe

Title: Difluoro antivirals and intermediate therefor
Abstract:A 2,2-difluoro-2-desoxycarbohydrate is used to prepare antiviral nucleosides.
Inventor(s): Hertel; Larry W. (Indianapolis, IN)
Assignee: Eli Lilly and Company (Indianapolis, IN)
Application Number:07/058,219
Patent Claims: 1. A nucleoside of the formula ##STR11## wherein R is a base selected from the group consisting of ##STR12## wherein R.sup.1 is hydrogen, methyl, bromo, fluoro, chloro oriodo;

R.sup.2 is hydroxy;

R.sup.3 is hydrogen, bromo, chloro or iodo.

2. A nucleoside of claim 1 wherein the carbohydrate moiety is in the ribose form.

3. A nucleoside of claim 2 wherein the base is of the formula ##STR13##

4. A nucleoside of claim 1 wherein the base is of the formula ##STR14##

5. A nucleoside of claim 4 wherein R.sup.1 is methyl.

6. A nucleoside of claim 3 wherein R.sup.1 is methyl.

7. A nucleoside of claim 1 wherein the base is of the formula ##STR15##

8. A nucleoside of claim 2 wherein the base is of the formula ##STR16##

9. A nucleoside of claim 7 wherein R.sup.1 is iodo.

10. A nucleoside of claim 8 wherein R.sup.1 is iodo.

11. A nucleoside of claim 7 wherein R.sup.1 is hydrogen.

12. A nucleoside of claim 8 wherein R.sup.1 is hydrogen.

13. A method of treating Herpes viral infections in mammals comprising administering to a mammal in need of such treatment an anti-Herpes viral effective amount of a compound of claim 1.

14. A pharmaceutical composition useful for treating Herpes viral infections comprising an anti-Herpes viral effective amount of a compound of claim 1 and a pharmaceutically-acceptable carrier, diluent or excipient therefor.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Deloitte
Chubb
Citi
Harvard Business School
Daiichi Sankyo
Healthtrust
AstraZeneca
Baxter
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot